Abstract
Endemic communities of Mansonella perstans infections have been neglected since associated pathology remains undefined. Consequently, improvements in drug therapy have also been ignored despite a large number of infected individuals in areas of Cameroon. Thus, we established an in vitro system to culture M. perstans microfilariae (Mf); the transmission stage of infection. In short, we compared the ability of two renowned culture media (Dulbecco's Modified Eagle's Medium (DMEM) and Roswell Park Memorial Institute (RPMI-1640)) to sustain Mf in culture. Media were supplemented with 10% fetal bovine serum (FBS) and monkey kidney epithelial cells (LLC-MK2) were used as feeder cells. As readout we assessed Mf survival and motility using a standardised microscopy assessment strategy. Moreover, this in vitro culture system was used to test susceptibility levels of microfilariae to different chemotherapeutic agents. Parasite motility was scored daily using a graded system and analysed using the average motility and area under the motility curve of M. perstans Mf. These datasets were analysed and discussed in detail in the related article entitled: “In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening” [1].
Keywords: Microfilariae motility, In vitro culture system, Mansonella perstans
Specifications Table
| Subject | Parasitology |
| Specific subject area | In vitro culture systems |
| Type of data | Table |
| How data were acquired | Microscopy |
| Data format | Raw and analysed |
| Parameters for data collection | In vitro cultures were performed by culturing 30–50 microfilariae/well in a 48-well flat-bottomed plate with or without a confluent monolayer of monkey kidney epithelial cells (LLC-MK2) as feeder cells in either RPMI-1640 or DMEM media supplemented with 5 μg/ml ciprofloxacin and 10 μg/ml fluconazole in the presence or absence of 10% fetal bovine serum (FBS). |
| Description of data collection | Microfilariae motility was scored daily using microscopy (x10 magnification) by applying a 4-point grading scale: 0, no movement or immotile; 1, intermittent shaking of head and tail; 2, sluggish (shaking of the whole form whilst the microfilariae remain stationary); 3, vigorous movement (shaking of the whole form with migration around the well). |
| Data accessibility | Within the article |
| Related research article | Njouendou AJ, Kien CA, Esum ME, Ritter M, Chounna Ndongmo WP, Fombad FF, Gandjui NVT, Njiokou F, Enyong P, Pfarr K, Turner J, Layland LE, Hoerauf A, Wanji S. “In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening.” Experimental Parasitology 2019; DOI: https://doi.org/10.1016/j.exppara.2019.107769 |
Value of the Data
|
1. Data
The findings presented here are based on the previous publication entilted “In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening” [1]. Data on the optimization of the in vitro culture conditions for the maintenance of M. perstans Mf are summarized in Table 1 (RPMI-1640) and Table 2 (DMEM), showing the daily average motility and areas under the curve (AUC) of M. perstans Mf activity.
Table 1.
Average motility and area under the curve (AUC) of M. perstans Mf activity during in vitro cultures containing RPMI-1640 medium supplemented with or without 10% fetal bovine serum (FBS) and/or monkey kidney epithelial feeder cells (LLC-MK2) over 20 days.
| Incubation days | Cell-free |
LLC-MK2 |
||
|---|---|---|---|---|
| Serum-free | 10% FBS | Serum-free | 10% FBS | |
| 0 | 100 | 100 | 100 | 100 |
| 1 | 99.58 | 99.3 | 100 | 99.78 |
| 2 | 81.02 | 98.29 | 100 | 100 |
| 3 | 72.25 | 95.76 | 100 | 100 |
| 4 | 41.86 | 84.84 | 100 | 100 |
| 5 | 28.46 | 82.31 | 100 | 100 |
| 6 | 26.5 | 80.68 | 100 | 100 |
| 7 | 25.36 | 79.1 | 100 | 100 |
| 8 | 25.36 | 79.1 | 100 | 100 |
| 9 | 25.24 | 79.1 | 100 | 100 |
| 10 | 25.24 | 79.1 | 100 | 100 |
| 11 | 25.24 | 79.1 | 100 | 100 |
| 12 | 25.24 | 79.1 | 100 | 100 |
| 13 | 25.24 | 79.1 | 100 | 99.63 |
| 14 | 25.24 | 79.1 | 100 | 100 |
| 15 | 25.24 | 79.1 | 100 | 99.62 |
| 16 | 25.24 | 79.1 | 100 | 99.63 |
| 17 | 25.24 | 79.1 | 100 | 99.46 |
| 18 | 25.24 | 79.1 | 100 | 99.46 |
| 19 | 25.38 | 78.73 | 100 | 99.46 |
| 20 |
25.38 |
78.73 |
100 |
99.46 |
| Average AUC (%) | 37.04 | 82.92 | 100 | 99.84 |
| p-valuea | – | 0.2623 | 0.0003 | 0.0034 |
Abbreviations. AUC: area under the curve.
Pairwise comparisons using Dunn's-test for multiple comparisons of independent samples. p-values presented in the table compare serum free and 10% FBS in the presence or absence of feeder cells (LLC MK2 cells).
Table 2.
Average motility and area under the curve (AUC) of M. perstans Mf activity during in vitro cultures containing DMEM medium supplemented with or without 10% fetal bovine serum (FBS) and/or monkey kidney epithelial feeder cells (LLC-MK2) over 20 days.
| Incubation days | Cell-free |
LLC-MK2 |
||
|---|---|---|---|---|
| Serum-free | 10% FBS | Serum-free | 10% FBS | |
| 0 | 100 | 100 | 100 | 100 |
| 1 | 99.2 | 99.49 | 100 | 100 |
| 2 | 99.3 | 98.83 | 100 | 99.76 |
| 3 | 88.97 | 95.17 | 100 | 99.76 |
| 4 | 80.04 | 87.43 | 100 | 99.76 |
| 5 | 77.55 | 84.41 | 100 | 99.76 |
| 6 | 77.8 | 79.37 | 100 | 99.76 |
| 7 | 77.64 | 79.26 | 100 | 99.76 |
| 8 | 77.52 | 79.26 | 100 | 99.76 |
| 9 | 77.71 | 79.26 | 100 | 99.76 |
| 10 | 77.71 | 78.99 | 100 | 99.76 |
| 11 | 77.71 | 79.26 | 100 | 99.76 |
| 12 | 77.71 | 79.26 | 100 | 99.76 |
| 13 | 77.71 | 79.26 | 100 | 99.42 |
| 14 | 77.71 | 79.26 | 99.72 | 99.42 |
| 15 | 77.71 | 79.26 | 100 | 99.42 |
| 16 | 77.71 | 79.26 | 100 | 99.42 |
| 17 | 77.71 | 79.26 | 100 | 99.42 |
| 18 | 77.71 | 79.26 | 100 | 99.42 |
| 19 | 77.71 | 79.13 | 100 | 99.42 |
| 20 |
77.71 |
79.13 |
100 |
99.42 |
| Average AUC (%) | 81.08 | 83.21 | 99.99 | 99.65 |
| p-valuea | – | 0.999 | 0.0041 | 0.0110 |
Abbreviations. AUC: area under the curve.
Pairwise comparisons using Dunn's-test for multiple comparisons of independent samples. p-values presented in the table compare each system to the serum free and cell free system.
2. Experimental design, materials, and methods
M. perstans Mf extracted from human blood were cultured in vitro as recently described for Loa loa parasites [[2], [3], [4]]. Briefly, 30–50 Mf/well were cultured in a 48-well flat-bottomed plate (Corning, New York, USA) with or without confluent monolayers of LLC-MK2 (LGC Standard GmbH, Wesel, Germany) as feeder cells in either RPMI-1640 or DMEM medium (Gibco, Cergy-Pontoise, France) supplemented with 5 μg/ml ciprofloxacin and 10 μg/ml fluconazole (Sigma Aldrich, St Louis, MO, USA) and in the presence or absence of 10% FBS (Lonza, Verviers, Belgium). Cultures were incubated at 37 °C and 5% CO2 for 20 days and helminth viability was evaluated by grading motility overtime. Mf motility was scored on a daily basis in a blind manner using x10 magnification with an inverted microscope (Motic, Wetzlar, Germany) by applying a 4-point scale:
-
-
0, no movement or immotile;
-
-
1, intermittent shaking of head and tail;
-
-
2, sluggish (shaking of the whole form whilst the Mf remain stationary);
-
-
3, vigorous movement (shaking of the whole form with migration around the well).
Raw data were saved in a spreadsheet and using the above described 4-point grading scale the percentage (%) of motility was calculated according to the following formula:
where Si is the score of point scale i and Ni is the total number of worms at a point scale I [5].
The mean of the area under curve (AUC) was calculated using the percentage motility of the drugs from 0 to 5 days according to the following formula:
where AUC = area under curve; y = motility; t = time point; n = an integer [6].
The effects of media and supplements on the Mf motility was compared using non-parametric tests. The Kruskal-Wallis one-way analysis test was used to assess the global significant differences between the median AUC and Dunn's post-hoc test was applied for pairwise multiple comparisons of the ranked data. This analysis was performed using the Pairwise Multiple Comparisons of Mean Rank Sums (PMCMR) package in R version 3.4.1 [7].
Acknowledgments
We sincerely thank the Mf-positive individuals for donating their blood in this study. In addition, we thank the German Research Foundation (DFG; Grant DFG HO2009/10-1; HO 2009/14-1) and the Federal Ministry of Education and Research (BMBF initiative Research Networks for Health Innovations in Sub-Sahara Africa: TAKeOFF) for financial support.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.dib.2019.104930.
Conflict of Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Njouendou A.J., Kien C.A., Esum M.E., Ritter M., Chounna Ndongmo W.P., Fombad F.F. In vitro maintenance of Mansonella perstans microfilariae and its relevance for drug screening. Exp. Parasitol. 2019;206:107769. doi: 10.1016/j.exppara.2019.107769. [DOI] [PubMed] [Google Scholar]
- 2.Zofou D., Fombad F.F., Gandjui N.V.T., Njouendou A.J., Kengne-Ouafo A.J., Chounna Ndongmo P.W. Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa. Parasites Vectors. 2018;11(1):275. doi: 10.1186/s13071-018-2852-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Njouendou A.J., Fombad F.F., O'Neill M., Zofou D., Nutting C., Ndongmo P.C. Heterogeneity in the in vitro susceptibility of Loa loa microfilariae to drugs commonly used in parasitological infections. Parasites Vectors. 2018;11(1):223. doi: 10.1186/s13071-018-2799-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Njouendou A.J., Ritter M., Ndongmo W.P.C., Kien C.A., Narcisse G.T.V., Fombad F.F. Successful long-term maintenance of Mansonella perstans in an in vitro culture system. Parasites Vectors. 2017;10(1):563. doi: 10.1186/s13071-017-2515-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Fombad F.F., Njouendou A.J., Ndongmo P.C., Ritter M., Chunda V.C., Metuge H.M. Effect of flubendazole on developing stages of Loa loa in vitro and in vivo: a new approach for screening filaricidal agents. Parasites Vectors. 2019;12(1):14. doi: 10.1186/s13071-018-3282-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Peacock J., Peacock J.L., Peacock P. Oxford University Press; 2011. Oxford Handbook of Medical Statistics. [Google Scholar]
- 7.R Core Team . 3.4.1 ed. Foundation for Statistical Computing; Vienna, Austria: 2014. A Language and Environment for Statistical Computing. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
